Clinical trial
Eplerenone, ACE Inhibition and Albuminuria
NCT00315016 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00315016 |
|---|---|
| Title | Eplerenone, ACE Inhibition and Albuminuria |
| Official title | Eplerenone, ACE Inhibition and Albuminuria |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | eplerenone, fosinopril, placebo |
| Enrollment | 30 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Apr 17, 2006 |
| Last update posted | May 28, 2012 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: